Efficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Pancreatic Adenocarcinoma: A Decision Analysis.
about
Neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of prospective studies.Clinical impact of neoadjuvant treatment in resectable pancreatic cancer: a systematic review and meta-analysis protocol.Preoperative lymphocyte-to-monocyte ratio predicts survival in primary hepatitis B virus-positive hepatocellular carcinoma after curative resection.Prognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinoma.Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.
P2860
Efficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Pancreatic Adenocarcinoma: A Decision Analysis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Efficacy of Neoadjuvant Versus ...... arcinoma: A Decision Analysis.
@en
type
label
Efficacy of Neoadjuvant Versus ...... arcinoma: A Decision Analysis.
@en
prefLabel
Efficacy of Neoadjuvant Versus ...... arcinoma: A Decision Analysis.
@en
P2093
P2860
P1476
Efficacy of Neoadjuvant Versus ...... arcinoma: A Decision Analysis.
@en
P2093
Daniel T Ruan
Edward E Whang
Gaurav Sharma
Hiromichi Ito
P2860
P2888
P304
P356
10.1245/S10434-015-4711-0
P478
22 Suppl 3
P577
2015-07-08T00:00:00Z
P6179
1052996982